These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25738375)

  • 21. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation.
    Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S
    J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission.
    Wakai M; Hayashi R; Tanaka S; Naito T; Kumada J; Nomura M; Takigawa H; Oka S; Ueno Y; Ito M; Chayama K
    BMC Gastroenterol; 2020 Apr; 20(1):85. PubMed ID: 32245401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count.
    Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission.
    Feagins LA; Melton SD; Iqbal R; Dunbar KB; Spechler SJ
    Inflamm Bowel Dis; 2013 Jun; 19(7):1477-82. PubMed ID: 23702713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological inflammatory activity can predict endoscopic relapse in patients with ulcerative colitis who have achieved mucosal healing.
    González-Partida I; Martínez-Lozano H; González-Lois C; Peligros I; Sánchez-Yuste R; Salas I; Matallana V; Bighelli F; Calvo M; Marín-Jiménez I; Salas C; Vera MI; Menchén L; González-Lama Y
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e796-e802. PubMed ID: 34334707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
    Arai M; Naganuma M; Sugimoto S; Kiyohara H; Ono K; Mori K; Saigusa K; Nanki K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Matsuoka K; Inoue N; Ogata H; Iwao Y; Kanai T
    J Crohns Colitis; 2016 Nov; 10(11):1303-1309. PubMed ID: 27194529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
    Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse.
    Nakarai A; Kato J; Hiraoka S; Takashima S; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H
    World J Gastroenterol; 2016 Jun; 22(21):5079-87. PubMed ID: 27275100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological healing after infliximab induction therapy in children with ulcerative colitis.
    Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
    World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test.
    Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K
    Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
    Muñoz Villafranca C; Bravo Rodríguez MT; Ortiz de Zárate J; Arreba González P; García Kamiruaga I; Heras Martín JI; Cabezudo Gil P; Orive Cura V
    Gastroenterol Hepatol; 2016; 39(7):442-8. PubMed ID: 26948837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score.
    Ikeya K; Hanai H; Sugimoto K; Osawa S; Kawasaki S; Iida T; Maruyama Y; Watanabe F
    J Crohns Colitis; 2016 Mar; 10(3):286-95. PubMed ID: 26581895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.
    Takashima S; Kato J; Hiraoka S; Nakarai A; Takei D; Inokuchi T; Sugihara Y; Takahara M; Harada K; Okada H; Tanaka T; Yamamoto K
    Am J Gastroenterol; 2015 Jun; 110(6):873-80. PubMed ID: 25823769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic and Histological Mucosal Healing in Ulcerative Colitis in the First Year of Diagnosis: Results from a Population-based Inception Cohort from Six Countries in Asia.
    Leung CM; Tang W; Kyaw M; Niamul G; Aniwan S; Limsrivilai J; Wang YF; Ouyang Q; Simadibrata M; Abdullah M; Ong DE; Yu HH; Zhang J; Ching J; Wu JCY; Chan FKL; Sung JJY; Ng SC
    J Crohns Colitis; 2017 Dec; 11(12):1440-1448. PubMed ID: 28961760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.
    Shimodaira Y; Watanabe K; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Scand J Gastroenterol; 2022 Feb; 57(2):165-168. PubMed ID: 34663142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.
    Fluxá D; Simian D; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Castro M; Piottante A; Vial MT; Quera R
    J Dig Dis; 2017 Nov; 18(11):634-641. PubMed ID: 28949435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
    Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
    Aloi M; DʼArcangelo G; Bramuzzo M; Gasparetto M; Martinelli M; Alvisi P; Illiceto MT; Valenti S; Distante M; Pellegrino S; Gatti S; Arrigo S; Civitelli F; Martelossi S;
    Inflamm Bowel Dis; 2016 Jul; 22(7):1647-54. PubMed ID: 27271489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.